HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older (some countries may allow people aged 16 or older, depending on local rules)
- People who have injected drugs at least once in the past month
- People who are currently using a Needle and Syringe Program (NSP) to get injecting equipment, whether at a fixed location, a mobile service, or through outreach, and who have been assigned a unique program ID through that service
- People who can understand and communicate in the local language used by the trial
- People who believe they do not have HCV (hepatitis C) or HIV and are willing to be tested for both as part of the trial
- People who are willing and able to give their informed consent to take part in the study
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mark Stoové, Burnet
Phone: +61 413 272 698
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effectiveness of a community values and preferences informed LDSS/N distribution program on increasing LDSS uptake among people who inject drugs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.